Skip to main content

Advertisement

ADVERTISEMENT

News

News
06/08/2016
The extended-release formulation of propiverine is "an effective and well-tolerated treatment option" for patients with symptoms of overactive bladder, according to a new study. In addition, the randomized, controlled, multicenter...
The extended-release formulation of propiverine is "an effective and well-tolerated treatment option" for patients with symptoms of overactive bladder, according to a new study. In addition, the randomized, controlled, multicenter...
The extended-release formulation...
06/08/2016
Population Health

Advertisement

News
11/24/2015
Management of overactive bladder often involves behavioral strategies such as fluid schedules, timed voiding, and bladder-holding techniques aided by strengthening the pelvic floor. These strategies are not always adequate, however.
Management of overactive bladder often involves behavioral strategies such as fluid schedules, timed voiding, and bladder-holding techniques aided by strengthening the pelvic floor. These strategies are not always adequate, however.
Management of overactive bladder...
11/24/2015
Annals of Long-Term Care
News Connection
01/20/2015

Mary Beth Nierengarten

Mary Beth Nierengarten
A systematic literature review was conducted to develop a clinical practice guideline for the dietary and pharmacologic management to prevent nephrolithiasis.
A systematic literature review was conducted to develop a clinical practice guideline for the dietary and pharmacologic management to prevent nephrolithiasis.
A systematic literature review...
01/20/2015
First Report Managed Care
News
12/15/2014
Onabotulinumtoxin-A (BoNT-A) is prescribed to treat both overactive bladder (OAB) and urinary incontinence due to detrusor overactivity associated with neurologic conditions in adult patients who have had an inadequate response to treatment...
Onabotulinumtoxin-A (BoNT-A) is prescribed to treat both overactive bladder (OAB) and urinary incontinence due to detrusor overactivity associated with neurologic conditions in adult patients who have had an inadequate response to treatment...
Onabotulinumtoxin-A (BoNT-A) is...
12/15/2014
Annals of Long-Term Care

Advertisement

News
07/10/2014

Sandy Bauers

Sandy Bauers
New study appears to show link between higher daily average temperatures and cases at hospitals and doctors' offices.
New study appears to show link between higher daily average temperatures and cases at hospitals and doctors' offices.
New study appears to show link...
07/10/2014
EMSWorld
News
05/26/2014
Intravesical instillation of liposomal onabotulinumtoxinA may be a promising, minimally-invasive approach for treatment of refractory overactive bladder, according to a new study.
Intravesical instillation of liposomal onabotulinumtoxinA may be a promising, minimally-invasive approach for treatment of refractory overactive bladder, according to a new study.
Intravesical instillation of...
05/26/2014
Pharmacy Learning Network
News
04/15/2014
Mirabegron offers an alternative to antimuscarinic drugs for older patients with overactive bladder, according to pooled data from several clinical trials.
Mirabegron offers an alternative to antimuscarinic drugs for older patients with overactive bladder, according to pooled data from several clinical trials.
Mirabegron offers an alternative...
04/15/2014
Pharmacy Learning Network

Advertisement

Advertisement